Anomalous Angiogenesis in Retina

Anomalous Angiogenesis in Retina

Age-related macular degeneration (AMD) may cause severe loss of vision or blindness, particularly in elderly people. Exudative AMD is characterized by the angiogenesis of blood vessels growing from underneath the macula, crossing the blood–retina barrier (which comprises Bruch’s membrane (BM) and th...

Full description

Bibliographic Details
Main Authors:	Rocío Vega, Manuel Carretero, Luis L Bonilla
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Biomedicines
Subjects:	cellular potts model exudative age-related macular degeneration angiogenesis notch signaling pathway systems biology
Online Access:	https://www.mdpi.com/2227-9059/9/2/224

Similar Items

Research advances in the regulatory role of Notch signaling pathway in the occurrence and development of eye diseases
by: Meng-Xian Zhou, et al.
Published: (2021-10-01)

Analysis on Conbercept for exudative age-related macular degeneration
by: Kun Li, et al.
Published: (2017-12-01)

Features of angiogenesis in eye diseases
by: T. A. Khalimov
Published: (2021-12-01)

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
by: Sam Razavi, et al.
Published: (2021-02-01)

Gut microbiota influences pathological angiogenesis in obesity‐driven choroidal neovascularization
by: Elisabeth MMA Andriessen, et al.
Published: (2016-12-01)

Oxidative Stress-Induced Cellular Senescence in Aging Retina and Age-Related Macular Degeneration
by: Ryo Terao, et al.
Published: (2022-11-01)

Retinal and choroidal angiogenesis: a review of new targets
by: Thiago Cabral, et al.
Published: (2017-08-01)

Role of IL-4 in bone marrow driven dysregulated angiogenesis and age-related macular degeneration
by: Takashi Baba, et al.
Published: (2020-05-01)

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
by: Omar A. Halawa, et al.
Published: (2021-06-01)

Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration
by: Blake H. Fortes, et al.
Published: (2023-09-01)

Retinal Vascularization Analysis on Optical Coherence Tomography Angiography before and after Intraretinal or Subretinal Fluid Resorption in Exudative Age-Related Macular Degeneration: A Pilot Study
by: Thibaud Mathis, et al.
Published: (2021-04-01)

Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration
by: Regina Lukacs, et al.
Published: (2023-03-01)

CLINICAL OUTCOMES OF THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PEGAPTANIB
by: M. Burova, et al.
Published: (2015-12-01)

Clinical outcomes of the treatment of exudative age-related macular degeneration with Pegaptanib
by: M. Burova, et al.
Published: (2013-02-01)

Removal of massive subretinal organized blood clot with fragmatome
by: San-Ni Chen, et al.
Published: (2021-01-01)

Association of exudative age-related macular degeneration with matrix metalloproteinases-2 (-1306 C/T) rs243865 gene polymorphism
by: Rasa Liutkeviciene, et al.
Published: (2018-01-01)

Incremental economic burden associated with exudative age-related macular degeneration: a population-based study
by: Siin Kim, et al.
Published: (2019-11-01)

“Decoding” angiogenesis: new facets controlling endothelial cell behavior
by: Massimo Mattia Santoro, et al.
Published: (2016-07-01)

Intravitreal injection of Conbercept in the treatment of exudative age-related macular degeneration
by: Hong-Xia Niu, et al.
Published: (2018-09-01)

Clinical observation of intravitreal injection of Conbercept treating exudative age-related macular degeneration
by: Wei Song, et al.
Published: (2016-07-01)

The Injection Practice Patterns of Retina Specialists in Managing Exudative Age-Related Macular Degeneration: A Retrospective Study
by: Karimaghaei C, et al.
Published: (2023-01-01)

Color Doppler imaging of the retrobulbar circulation and plasmatic biomarkers of vascular risk in age-related macular degeneration: A pilot study
by: Fermin Rodrigo, et al.
Published: (2018-01-01)

Causality between type 2 diabetes mellitus and age-related macular degeneration: a Mendelian randomization study
by: Zhao Liu, et al.
Published: (2023-09-01)

Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration
by: Chikako Hara, et al.
Published: (2024-01-01)

Effects of Disseminated Mycobacterial Infection on Age-Related Macular Degeneration
by: Geoffrey Collett, et al.
Published: (2016-11-01)

Caffeine Inhibits Choroidal Neovascularization Through Mitigation of Inflammatory and Angiogenesis Activities
by: Christine M. Sorenson, et al.
Published: (2021-10-01)

Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients
by: Kyung Tae Kim, et al.
Published: (2021-08-01)

Glycine-Conjugated Bile Acids Protect RPE Tight Junctions against Oxidative Stress and Inhibit Choroidal Endothelial Cell Angiogenesis In Vitro
by: Cassandra Warden, et al.
Published: (2021-04-01)

Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina
by: Fahad Farhan, et al.
Published: (2021-11-01)

ATP and Adenosine in the Retina and Retinal Diseases
by: Shan-Shan Ye, et al.
Published: (2021-06-01)

Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot Study
by: Robert J. Minturn, et al.
Published: (2021-02-01)

Influence of Multiple Anti-VEGF Injections on Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness in Patients with Exudative Age-Related Macular Degeneration
by: Maja Zivkovic, et al.
Published: (2023-01-01)

Posterior Vitreous Detachment and Its Role in the Evolution of Dry to Wet Age Related Macular Degeneration
by: Bakaliou A, et al.
Published: (2023-03-01)

Posterior Vitreous Detachment and Its Role in the Evolution of Dry to Wet Age Related Macular Degeneration [Letter]
by: Kusumawardhani SI
Published: (2023-03-01)

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration
by: Shaikh Saad, et al.
Published: (2007-01-01)

Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
by: Kaya C, et al.
Published: (2019-12-01)

Treatment for exudative age-related macular degeneration with Conbercept: a Meta-analysis
by: Chun-Xing Li, et al.
Published: (2018-06-01)

Research status of photodynamic therapy combined anti-VEGF drugs to treat exudative age-related macular degeneration
by: Ling Li, et al.
Published: (2015-02-01)

Ferrochelatase is a therapeutic target for ocular neovascularization
by: Halesha D Basavarajappa, et al.
Published: (2017-06-01)

Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review
by: Kah-Hui Wong, et al.
Published: (2022-01-01)